<DOC>
	<DOC>NCT00193661</DOC>
	<brief_summary>This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).</brief_summary>
	<brief_title>Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Primary or secondary hypogonadism or constitutional delay in growth and puberty (CDGP) Skin intolerance to alcohol or allergy to soy Generalized skin disease Contraindication to testosterone or androgen products</criteria>
	<gender>Male</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Hypogonadism</keyword>
</DOC>